Sensus publishes data on superficial radiotherapy technology, punch excision

Sensus Healthcare (SRTS) announced that a study published in Dermatologic Therapy demonstrates the safety and efficacy of the company’s superficial radiotherapy technology combined with punch excision to treat keloids. The article, titled “Efficacy of Punch Excision Combined With Superficial X-Ray for the Treatment of Keloids: A Single-Center Retrospective Study,” evaluates 60 patients treated with a combination of punch excision and superficial X-ray therapy at the Hospital for Skin Diseases in Nanjing, China. The punch excision better enables SRT penetration to induce fibroblast apoptosis, yielding a synergistic therapeutic effect. Results showed a statistically significant improvement in patient outcomes, with notable reductions in pain, itching, thickness and irregularity of keloid scars after one year of follow-up. No severe adverse reactions were reported, reinforcing the safety profile of SRT.